Bovine Blood Plasma Derivatives Market – Industry Analysis and Forecast (2022-2029)


Bovine Blood Plasma Derivatives Market is expected to reach US$ 2.58 Bn. at a CAGR of 4.3 % during the forecast period 2029.

The global Bovine Blood Plasma Derivatives market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Bovine Blood Plasma Derivatives report also provides trends by market segments, technology, and investment with a competitive landscape.Bovine Blood Plasma Derivatives MarketTo know about the Research Methodology :- Request Free Sample Report

Bovine Blood Plasma Derivatives Market Overview:

Bovine blood plasma derivatives are proteins extracted from the blood plasma of bovine animals by physicochemical or other fractionation processes. Factor VIII and IX Concentrates, Anti-Inhibitor Coagulation Complex (AICC), Albumin, immunoglobulins, including Rh Immune Globulin, Anti-Thrombin III Concentrate, and Alpha 1-Proteinase Inhibitor Concentrates are all found in bovine blood plasma. Protein structure analysis, sequence analysis, and biochemical research all use plasma derivatives.

Bovine Blood Plasma Derivatives Market Dynamics:

Drivers:

Increased use of bovine blood plasma derivatives in the food industry, which is seeing a rise in demand for nutritious foods, is one of the market's main drivers. Furthermore, advances in blood storage and processing technologies are propelling the industry forward in a positive direction. Firms are growing their research and development budgets as a result of a wide range of applications, which can be seen as a good opportunity.

The increasing use of bovine blood plasma derivatives in biopharmaceutical companies for a variety of applications such as cell culture technique, biotechnology, and research and development is expected to drive market growth.

The market is expected to benefit from the advancement of improved methods for the preservation of plasma derivatives, as well as advanced fractionation procedures and high potential in untapped markets in emerging economies.

Restraints:

On the other hand, the availability of substitutes for bovine blood plasma derivatives, may limit the market's growth over the forecast period. Furthermore, market development is hampered by factors such as the high cost of plasma derivative-based therapy and the post-operative complications associated with plasma replacement therapy.

Bovine Blood Plasma Derivatives Market Segment Analysis:

Based on Product Type, the thrombin segment accounted for the highest demand, owing to its increased use in surgeries and diagnostic procedures. In vitro studies, coagulation testing, protein structure analysis, medical research, and biochemical research are all examples of thrombin R&D applications.

Based on the application, the cell culture/biotechnology industry holds the largest share of the bovine blood plasma derivatives market followed by the food industry. And, until 2029, both are expected to be the most lucrative application category. The importance of bovine blood plasma derivatives has increased in recent years, not only in traditional research but also in the creation and production of essential biomolecules and therapeutics.

Bovine Blood Plasma Derivatives Market Regional Insights:

North America, especially the United States, plays a significant role in the global bovine blood plasma derivatives market, with a significant impact on the production of bovine blood plasma derivatives.

Germany, the United Kingdom, France, and Italy all play significant roles in the European market, especially Germany, which has complete dominance.

Due to strong demand from China, India, and Southeast Asian countries, the Asia-Pacific will play an increasingly important role in the global bovine blood plasma derivatives market. Government policies and approvals to export products like cattle protein and serum are credited with driving market growth in the region.

The objective of the report is to present a comprehensive analysis of the global Bovine Blood Plasma Derivatives market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Bovine Blood Plasma Derivatives market dynamics, structure by analyzing the market segments and project the global Bovine Blood Plasma Derivatives market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Bovine Blood Plasma Derivatives market make the report investor’s guide.

Bovine Blood Plasma Derivatives Market Key Developments:

Proliant Biologicals released its Ultra-High Monomer BSA solution in February 2021, intending to improve the efficiency of BSA in critical research.

Bovine Blood Plasma Derivatives Market Scope: Inquire before buying 






Global Bovine Blood Plasma Derivatives Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 1.84 Bn.




Forecast Period 2022 to 2029 CAGR:
4.3%
Market Size in 2029:
US $ 2.58 Bn.




 Segments Covered:
By Product Type
•Bovine Serum
•Fetal Bovine Serum
•Bovine Serum Albumin
•Fibrinogen
•Thrombin
•Transferrin
•New Born Calf Serum
•Others




By Application
•Pharmaceutical Industry
•Diagnostic Industry
•Cell Culture/Biotechnology
•Food Industry
•Others






Bovine Blood Plasma Derivatives Market, by Region

• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• South America

Bovine Blood Plasma Derivatives Market Key Players are:

• Thermo Fisher Scientific, Inc.
• GE Healthcare
• Merck (Sigma-Aldrich)
• Moregate BioTech
• Rocky Mountain Biologics, Inc.
• Auckland BioSciences, Ltd.
• Gemini
• Atlanta Biologicals
• Tissue Culture Biologicals
• Bovogen
• Biowest
• Interngocios
• Proliant, Inc.
• Biological Industries
• Lake Immunogenics, Inc.
• AusgeneX
• Other Key Players

Frequently Asked Questions:

1. Which region has the largest share in Global Bovine Blood Plasma Derivatives Market?
Ans: North America region held the highest share in 2021.

2. What is the growth rate of Global Bovine Blood Plasma Derivatives Market?
Ans: The Global Bovine Blood Plasma Derivatives Market is growing at a CAGR of 4.3% during forecasting period 2022-2029.

3. What is scope of the Global Bovine Blood Plasma Derivatives market report?
Ans: Global Bovine Blood Plasma Derivatives Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Bovine Blood Plasma Derivatives market?
Ans: The important key players in the Global Bovine Blood Plasma Derivatives Market are - Thermo Fisher Scientific, Inc., GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Rocky Mountain Biologics, Inc., Auckland BioSciences, Ltd., Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Interngocios, Proliant, Inc., Biological Industries, Lake Immunogenics, Inc., AusgeneX, and Other Key Players

5. What is the study period of this market?
Ans: The Global Bovine Blood Plasma Derivatives Market is studied from 2021 to 2029. 




1.Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Bovine Blood Plasma Derivatives Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2022
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Bovine Blood Plasma Derivatives Market
3.4. Geographical Snapshot of the Bovine Blood Plasma Derivatives Market, By Manufacturer share
4. Global Bovine Blood Plasma Derivatives Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Bovine Blood Plasma Derivatives Market
5. Supply Side and Demand Side Indicators
6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2022-2029
6.1. Global Bovine Blood Plasma Derivatives Market Size & Y-o-Y Growth Analysis.
7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
7.1.1. Bovine Serum
7.1.2. Fetal Bovine Serum
7.1.3. Bovine Serum Albumin
7.1.4. Fibrinogen
7.1.5. Thrombin
7.1.6. Transferrin
7.1.7. New Born Calf Serum
7.1.8. Others
7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
7.2.1. Pharmaceutical Industry
7.2.2. Diagnostic Industry
7.2.3. Cell Culture/Biotechnology
7.2.4. Food Industry
7.2.5. Others
8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
9.1.1. Bovine Serum
9.1.2. Fetal Bovine Serum
9.1.3. Bovine Serum Albumin
9.1.4. Fibrinogen
9.1.5. Thrombin
9.1.6. Transferrin
9.1.7. New Born Calf Serum
9.1.8. Others
9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
9.2.1. Pharmaceutical Industry
9.2.2. Diagnostic Industry
9.2.3. Cell Culture/Biotechnology
9.2.4. Food Industry
9.2.5. Others
10. North America Bovine Blood Plasma Derivatives Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
12. Canada Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
13. Mexico Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
14. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
15. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
17. France Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
18. Germany Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
19. Italy Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
20. Spain Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
21. Sweden Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
22. CIS Countries Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
23. Rest of Europe Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
24. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
25. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
27. India Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
28. Japan Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
29. South Korea Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
30. Australia Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
31. ASEAN Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
32. Rest of Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
33. Middle East Africa Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
34. Middle East Africa Bovine Blood Plasma Derivatives Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
36. GCC Countries Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
37. Egypt Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
38. Nigeria Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
39. Rest of ME&A Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
40. South America Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
41. South America Bovine Blood Plasma Derivatives Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
43. Argentina Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
44. Rest of South America Bovine Blood Plasma Derivatives Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Bovine Blood Plasma Derivatives Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile: Key Players
45.3.1. Thermo Fisher Scientific, Inc.
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. GE Healthcare
45.3.3. Merck (Sigma-Aldrich)
45.3.4. Moregate BioTech
45.3.5. Rocky Mountain Biologics, Inc.
45.3.6. Auckland BioSciences, Ltd.
45.3.7. Gemini
45.3.8. Atlanta Biologicals
45.3.9. Tissue Culture Biologicals
45.3.10. Bovogen
45.3.11. Biowest
45.3.12. Interngocios
45.3.13. Proliant, Inc.
45.3.14. Biological Industries
45.3.15. Lake Immunogenics, Inc.
45.3.16. AusgeneX
45.3.17. Other Key Players
46. Primary Key Insights
  • INQUIRE BEFORE BUYING